These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 38735628)

  • 1. Pseudomonas aeruginosa bloodstream infections in children and adolescents: risk factors associated with carbapenem resistance and mortality.
    Rodríguez NEG; Aguilera-Alonso D; Escosa L; Gómez-Gil MR; Manzanares Á; Ascaso MG; Bermejo-Gómez A; Abad MJG; Ramos AM; Núñez AS; Orellana MÁ; Cercenado E; Lozano JS; Calvo C; Baquero-Artigao F;
    J Hosp Infect; 2024 Jul; 149():56-64. PubMed ID: 38735628
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A retrospective analysis of
    Shi Q; Huang C; Xiao T; Wu Z; Xiao Y
    Antimicrob Resist Infect Control; 2019; 8():68. PubMed ID: 31057792
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Risk factors for pan-resistant Pseudomonas aeruginosa bacteremia and the adequacy of antibiotic therapy.
    Tuon FF; Gortz LW; Rocha JL
    Braz J Infect Dis; 2012; 16(4):351-6. PubMed ID: 22846123
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Risk factors and mortality of carbapenem-resistant Pseudomonas aeruginosa bloodstream infection in haematology department: A 10-year retrospective study.
    Yuan F; Li M; Wang X; Fu Y
    J Glob Antimicrob Resist; 2024 Jun; 37():150-156. PubMed ID: 38615882
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Influence of carbapenem resistance on mortality and the dynamics of mortality in Pseudomonas aeruginosa bloodstream infection.
    Suárez C; Peña C; Gavaldà L; Tubau F; Manzur A; Dominguez MA; Pujol M; Gudiol F; Ariza J
    Int J Infect Dis; 2010 Sep; 14 Suppl 3():e73-8. PubMed ID: 20223693
    [TBL] [Abstract][Full Text] [Related]  

  • 6.
    Herrera S; Morata L; Sempere A; Verdejo M; Del Rio A; Martínez JA; Cuervo G; Hernández-Meneses M; Chumbita M; Pitart C; Puerta P; Monzó P; Lopera C; Aiello F; Mendoza S; Garcia-Vidal C; Soriano A; Bodro M
    Antibiotics (Basel); 2023 Feb; 12(2):. PubMed ID: 36830291
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Risk factors and clinical significance of bacteremia caused by Pseudomonas aeruginosa resistant only to carbapenems.
    Lee CH; Su TY; Ye JJ; Hsu PC; Kuo AJ; Chia JH; Lee MH
    J Microbiol Immunol Infect; 2017 Oct; 50(5):677-683. PubMed ID: 26188977
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Risk Factors for Infection and Mortality Associated With Stenotrophomonas maltophilia Bloodstream Infections in Children; Comparison With Pseudomonas aeruginosa Bloodstream Infections.
    Bilen NM; Sahbudak Bal Z; Güner Özenen G; Yildirim Arslan S; Ozek G; Ozdemir Karadas N; Yazici P; Cilli F; Kurugöl Z
    Pediatr Infect Dis J; 2023 May; 42(5):374-380. PubMed ID: 36795557
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rectal culture could predict carbapenem-resistant organism bloodstream infection and reduce the mortality in haematological patients: A retrospective cohort study.
    Gao S; Yan R; Zhang S; Li L; Zhang R; Fan J; Qin J; Peng Y; Wan D; Cao W; Bian Z
    J Glob Antimicrob Resist; 2024 Mar; 36():96-104. PubMed ID: 38128727
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prospective multicenter study of the impact of carbapenem resistance on mortality in Pseudomonas aeruginosa bloodstream infections.
    Peña C; Suarez C; Gozalo M; Murillas J; Almirante B; Pomar V; Aguilar M; Granados A; Calbo E; Rodríguez-Baño J; Rodríguez F; Tubau F; Martínez-Martínez L; Oliver A;
    Antimicrob Agents Chemother; 2012 Mar; 56(3):1265-72. PubMed ID: 22155832
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mortality associated with carbapenem-susceptible and Verona Integron-encoded Metallo-β-lactamase-positive Pseudomonas aeruginosa bacteremia.
    Persoon MC; Voor In't Holt AF; Wielders CCH; Gommers D; Vos MC; Severin JA
    Antimicrob Resist Infect Control; 2020 Feb; 9(1):25. PubMed ID: 32014058
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Predictors of Mortality in Bloodstream Infections Caused by Pseudomonas aeruginosa and Impact of Antimicrobial Resistance and Bacterial Virulence.
    Recio R; Mancheño M; Viedma E; Villa J; Orellana MÁ; Lora-Tamayo J; Chaves F
    Antimicrob Agents Chemother; 2020 Jan; 64(2):. PubMed ID: 31767719
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of carbapenem exposure on the risk for digestive tract carriage of intensive care unit-endemic carbapenem-resistant Pseudomonas aeruginosa strains in critically ill patients.
    Peña C; Guzmán A; Suarez C; Dominguez MA; Tubau F; Pujol M; Gudiol F; Ariza J
    Antimicrob Agents Chemother; 2007 Jun; 51(6):1967-71. PubMed ID: 17420207
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Risk Factors and Outcomes of Antibiotic-resistant Pseudomonas aeruginosa Bloodstream Infection in Adult Patients With Acute Leukemia.
    Zhao Y; Lin Q; Liu L; Ma R; Chen J; Shen Y; Zhu G; Jiang E; Mi Y; Han M; Wang J; Feng S
    Clin Infect Dis; 2020 Dec; 71(Suppl 4):S386-S393. PubMed ID: 33367574
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Incidence, antimicrobial resistance and mortality of
    Xiao S; Liang X; Han L; Zhao S
    Front Public Health; 2023; 11():1294141. PubMed ID: 38249405
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Socioeconomic burden of bloodstream infections caused by carbapenem-resistant and carbapenem-susceptible Pseudomonas aeruginosa in China.
    Yang K; Xiao T; Shi Q; Zhu Y; Ye J; Zhou Y; Xiao Y
    J Glob Antimicrob Resist; 2021 Sep; 26():101-107. PubMed ID: 34023532
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pseudomonas aeruginosa bacteraemia in patients with hematologic malignancies: risk factors, treatment and outcome.
    Tofas P; Samarkos M; Piperaki ET; Kosmidis C; Triantafyllopoulou ID; Kotsopoulou M; Pantazatou A; Perlorentzou S; Poulli A; Vagia M; Daikos GL
    Diagn Microbiol Infect Dis; 2017 Aug; 88(4):335-341. PubMed ID: 28529091
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rates, predictors and mortality of community-onset bloodstream infections due to Pseudomonas aeruginosa: systematic review and meta-analysis.
    Rojas A; Palacios-Baena ZR; López-Cortés LE; Rodríguez-Baño J
    Clin Microbiol Infect; 2019 Aug; 25(8):964-970. PubMed ID: 30995530
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical characteristics and outcomes of Pseudomonas aeruginosa bacteremia in febrile neutropenic children and adolescents with the impact of antibiotic resistance: a retrospective study.
    Kim HS; Park BK; Kim SK; Han SB; Lee JW; Lee DG; Chung NG; Cho B; Jeong DC; Kang JH
    BMC Infect Dis; 2017 Jul; 17(1):500. PubMed ID: 28716109
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Carbapenem-resistant Pseudomonas aeruginosa in Taiwan: Prevalence, risk factors, and impact on outcome of infections.
    Lin KY; Lauderdale TL; Wang JT; Chang SC
    J Microbiol Immunol Infect; 2016 Feb; 49(1):52-9. PubMed ID: 24662016
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.